Identification of a Zn2+-binding site on the dopamine D2 receptor

被引:19
|
作者
Liu, Y
Teeter, MM
DuRand, CJ
Neve, KA [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA
[2] Portland Vet Affairs Med Ctr, Portland, OR 97239 USA
[3] Univ Calif Davis, Dept Psychiat, Davis, CA 95616 USA
[4] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA
[5] Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA
关键词
allosteric modulation; zinc ion-binding site; dopamine D-2 receptor; site-directed mutagenesis;
D O I
10.1016/j.bbrc.2005.11.110
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Zinc (II) modulates the function of many integral membrane proteins. To identify the Zn2+-binding site responsible for allosteric modulation of the D-2 dopamine receptor, we first demonstrated that the binding site is likely located in extracellular loops or in transmembrane regions that are accessible from the extracellular milieu. We mutated every histidine in these regions to alanine; two mutants, H394A and H399A, exhibited a reduced response to Zn2+. Combined mutation of H394 and H399 caused a larger effect of zinc than did either single mutation. Mutation of other potential Zn2+-binding residues predicted to be in proximity to H394 or H399 did not substantially alter the potency of Zn2+. The double mutant H394A/H399A was similar to D-2 in affinity for [H-3]spiperone and ability to inhibit cyclic AMP accumulation. We conclude that binding of Zn2+ to H394 and H399 on the dopamine D, receptor contributes to allosteric regulation of antagonist binding. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:873 / 879
页数:7
相关论文
共 50 条
  • [31] Extrastriatal Dopamine D2 Receptor Binding in Huntington's Disease
    Esmaeilzadeh, Mouna
    Farde, Lars
    Karlsson, Per
    Varrone, Andrea
    Halldin, Christer
    Waters, Susanna
    Tedroff, Joakim
    HUMAN BRAIN MAPPING, 2011, 32 (10) : 1626 - 1636
  • [32] Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor
    Torvinen, M
    Kozell, LB
    Neve, KA
    Agnati, LF
    Fuxe, K
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2004, 24 (02) : 173 - 180
  • [33] Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release
    Berry, Anne S.
    Shah, Vyoma D.
    Furman, Daniella J.
    White, Robert L., III
    Baker, Suzanne L.
    O'Neil, James P.
    Janabi, Mustafa
    D'Esposito, Mark
    Jagust, William J.
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 (06) : 1201 - 1211
  • [34] Effects of dopamine on the in vivo binding of dopamine D2 receptor radioligands in rat striatum
    Moresco, RM
    Loc'h, C
    Ottaviani, M
    Guibert, B
    Leviel, V
    Maziere, M
    Fazio, F
    Maziere, B
    NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (01) : 91 - 98
  • [35] Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release
    Anne S Berry
    Vyoma D Shah
    Daniella J Furman
    Robert L White III
    Suzanne L Baker
    James P O’Neil
    Mustafa Janabi
    Mark D’Esposito
    William J Jagust
    Neuropsychopharmacology, 2018, 43 : 1201 - 1211
  • [36] μ-Receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man
    Hagelberg, N
    Kajander, JK
    Någren, K
    Hinkka, S
    Hietala, J
    Scheinin, H
    SYNAPSE, 2002, 45 (01) : 25 - 30
  • [37] Distinct Dopamine D2 Receptor Antagonists Differentially Impact D2 Receptor Oligomerization
    Wouters, Elise
    Ricarte Marin, Adrian
    Rupert Dalton, James Andrew
    Giraldo, Jesus
    Stove, Christophe
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07)
  • [38] MAPPING THE BINDING-SITE CREVICE OF THE DOPAMINE D2 RECEPTOR BY THE SUBSTITUTED-CYSTEINE ACCESSIBILITY METHOD
    FU, D
    CHEN, J
    KARLIN, A
    JAVITCH, JA
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 : S28 - S28
  • [39] MAPPING THE BINDING-SITE CREVICE OF THE DOPAMINE D2 RECEPTOR BY THE SUBSTITUTED-CYSTEINE ACCESSIBILITY METHOD
    JAVITCH, JA
    FU, DY
    CHEN, JY
    KARLIN, A
    NEURON, 1995, 14 (04) : 825 - 831
  • [40] Tropapride docked to dopamine D2 receptor model explains mutagenesis at the putative sodium binding site.
    Teeter, MM
    DuRand, CJ
    Neve, KA
    Froimowitz, M
    BIOPHYSICAL JOURNAL, 2001, 80 (01) : 353A - 353A